Our Consultants Specializing in Regulatory Affairs for Drug-related Matters in Ukraine
We comprehend the diverse phases that both companies and programs undergo and can provide you with customizable services—an adaptable and cost-efficient approach to acquiring the essential startup services.
Our extensive array of support choices offers solutions that beneficially influence your development program. As your program evolves, we adapt and expand alongside you. Our advantage is that we back your program from its inception, ensuring familiarity with the entire history of your development plan.
Comprehensive clinical assistance for global Phase I-IV studies
We offer comprehensive clinical assistance for global Phase I-IV studies, covering the entire spectrum from initiation to conclusion. Our interdisciplinary team, comprising scientific and clinical operations experts, collaborates with you and your strategic partners to proactively address and overcome challenges associated with intricate program design, clinical trial execution, and regulatory approval.
Ensuring Full Adherence to Local and International Standards
Navigating the intricate journey of introducing new pharmaceutical and medical device products to the market can be challenging, expensive, and time-intensive. Whether your novel product falls under the category of drugs, medical devices, or a combination of both, our team possesses a deep understanding of regulatory requirements. We boast the resources and proven expertise necessary to align with your goals for clinical trial approval.
Our comprehensive approach to development encompasses a meticulous evaluation of the regulatory environment globally
We identify regulatory pathways and determine the target market, clinical development trajectory, and commercialization strategy for the product. To initiate the strategic planning process, it is essential to gain a clear understanding of the target patient population, their unmet needs, and subsequently devise a clinical development pathway. This pathway includes identifying the necessary trials for regulatory approval. A well-researched strategic plan, developed in collaboration with subject matter and regulatory experts, proves pivotal in saving time, resources, and costs.
The rapid pace of drug development in the global market places significant pressure on sponsors to convey value and enhance access to new treatments
Defining treatment value in today's intricate environment is a formidable task that should commence at the earliest stages of your development program. We provide our Health Economics and Outcomes Research (HEOR) expertise as early as Phase 2, allowing sponsors to stay ahead of the curve. It's important to note that incorporating HEOR principles at this early stage should not impose undue burdens on the development program. Instead, they should be integrated as integral aspects of your program, offering insights that contribute to advancing and communicating the value of the treatment.
Let us know how we can help.
You can get in touch for information about our services and much more!
Our location:
Na bahnech 574/21, Čakovice 196 00 Praha 9
Follow Us: